Key Rating Drivers & Detailed Description
Strengths:
- Strategic importance to, and expectation of high-quality support from the parent companies
HDFC ERGO is strategically important to its parents, HDFC and ERGO International AG (the primary insurance entity of Munich Reinsurance group) and derives significant managerial and funding support from them. Strong managerial support from HDFC is reflected in its sizeable representation on HDFC ERGO’s board, commonality of chairman and its strong involvement in HDFC ERGO’s functioning. ERGO International AG also has two non-executive directors on HDFC ERGO’s board and provides technical support, if needed. Both the parents have also demonstrated timely financial support, whenever needed. HDFC ERGO also benefits from common branding with HDFC, which is the largest housing finance company in India with a strong retail presence, solid brand image, established franchise, and large customer base. CRISIL Ratings believes that both parent companies will continue to support HDFC ERGO’s growth plans and will contribute to any incremental capital requirement whenever needed.
HDFC ERGO’s strategic importance to HDFC is underpinned by the former’s strong market position and expectation of gradual improvement in its underwriting profitability over the medium term. Furthermore, HDFC ERGO being the general insurance arm of HDFC group makes it a key element of the latter’s suit of financial service offerings. The strategic importance of HDFC ERGO to HDFC is also reflective in the support extended by the latter in the inorganic expansion of the subsidiary through acquisition of HDFC ERGO Health Insurance Company Ltd (HEHI; erstwhile Apollo Munich Health Insurance Company Ltd).
On April 4th, 2022, the Board of Directors of HDFC and HDFC Bank respectively approved a composite scheme of amalgamation (“Scheme”) inter alia involving merger of HDFC with and into HDFC Bank subject to receipt of requisite approvals/ no objections including from Reserve Bank of India (RBI) and other statutory and regulatory authorities. Post the merger amalgamation becoming effective, HDFC Bank will hold the shares held by HDFC Ltd in the Company. The developments pertaining to this amalgamation and, the ultimate shareholding of HDFC Bank in HDFC ERGO subsequent to the scheme coming into effect, will remain a key monitorable.
- Established market position in the Indian general insurance sector
HDFC ERGO, having been in operations for close to two decades now, has a strong market position with a market share of 6.1% % based on the gross direct premium written during fiscal 2022 – which makes it the third largest private general insurer and, seventh largest at an overall level. The company’s gross direct premium for fiscal 2022 was Rs 13,498 crore which marks a rise of 10% over gross premiums written in the preceding fiscal. For H1 2023, the year-on-year growth in gross premiums was 22.6%.
In the last 3-5 years, the company has expanded inorganically which has strengthened its market position within key insurance segments like motor and health. After its reverse merger with HDFC General (erstwhile L&T General Insurance Company Ltd), HDFC ERGO’s position in the motor segment was bolstered by the established distribution network of the former. And subsequently, post amalgamation of HEHI with HDFC ERGO, HDFC ERGO’s agency channel has widened which would benefit its market position in the health insurance segment in the long run. In terms of portfolio mix, health, motor, fire and crop have remained the key focus areas. Based on the gross direct premiums for H1 2023, the share of health insurance stood at 27.5% as against its share of below 20% prior to amalgamation with HEHI. This increase in share of health portfolio is in line with CRISIL Ratings’ earlier expectations. Motor, as the second largest segment, formed 25.5% % of the total premiums followed by fire, which accounted for 12.5% and has emerged as one of the key segments after a favourable revision in rates w.e.f January 2020 which has catalysed growth in this segment across the sector. The share of crop segment was 21.5% in the total premiums written during H1 2023. Since premium inflow within this segment happens in the latter half of the fiscal, its share is expected to remain at similar levels for rest of the fiscal.
HDFC ERGO also has a strong distribution network supported by its association with HDFC group, and channel relations acquired through inorganic routes. For H1 2023 nearly 14% % of business is sourced by corporate agents as against 10% for most other large players in the industry. This reduces dependency on brokers and direct mode of origination.
CRISIL Ratings believes that HDFC ERGO shall sustain its market position in due course supported by its diversified portfolio and distribution network. However, its ability to sustain the momentum in growth, apart from the inorganic expansion that it undertakes, amid intense competition will remain a key rating sensitivity factor.
- Robust risk management practices and sound investment quality
HDFC ERGO has institutionalized a comprehensive risk management framework to identify, assess and monitor risks. Apart from insurance risk, the risk management framework also addresses strategic risks, operational risks, investment risks and information and cyber security risks. The company undertakes only those businesses where risks can be measured quantitatively. Moreover, a large proportion of the exposure is reinsured, thereby limiting the risks on books. The company also has a diversified panel of reinsurers, all rated ‘BBB+’ or above on international rating scale. The company, on average, retains 50-55% of its business, which is significantly lower than peers.
These practices have enabled the company to maintain adequate level of cushion in available solvency margin over and above the economic capital requirement and, have also ensured lesser volatility in the solvency margin of the company over the years, as compared to that exhibited by its peers. Over the medium term, the company’s robust risk management practices are expected support the sustenance in its operating performance.
HDFC ERGO also has a sound investment portfolio quality supported by its prudent investment policy and stringent regulations. As on September 30, 2022, 99.7% of its debt investments are in securities rated ‘AA’ or higher or are sovereign securities. In addition, liquidity is comfortable, with a large proportion of liquid investments. Government securities (G-secs) accounted for 46% (central and state) of its investment portfolio based on market value on September 30, 2022. The company’s conservative investment philosophy is also depicted by its low exposure of less than 6% to equity investments and, the steady state stance of maintaining equity exposure within 10%.
Capitalisation, in relation to the nature and scale of the company’s operations, remains comfortable. On September 30, 2022, the company had a reported networth of Rs 3,533 crore (excluding amalgamation reserves) and a solvency ratio of 1.78 times. Apart from its reported metrics, capital position of HDFC ERGO is backed by expectation of timely capital infusion from its parents, if needed, as demonstrated in the past.
CRISIL Ratings believes HDFC ERGO’s capital position will remain adequate, supported by opportune financial support from its parents and steady internal accruals. The company is also expected to sustain the cushion over and above regulatory solvency requirement at current levels, on an on-going basis.
Weakness:
- Modest underwriting performance with overall earnings profile remaining supported by investment income
HDFC ERGO’s underwriting performance, despite gradual improvement over the years, remains modest. For fiscal 2022, the company reported a combined ratio of 107.5% as compared to 103.2% for the previous fiscal. Over this period, where the claims ratio increased to 84.0% from 75.7% due to surge in Covid-19 claims, expense ratio restored to 23.4% from 27.5% as last year the company incurred amalgamation related expenses which led to a rise in expenses. Underwriting deficit for fiscal 2022 was Rs 568 crore as compared to Rs 235 crore for the previous fiscal. For fiscal 2021 and 2022, Covid-19 claims were on the higher side which resulted in an elevated claims ratio especially after the second wave in fiscal 2022. However, as the Covid instances have tailed out – claims ratio is expected to correct in the near term. As prudence, the company is still carrying provisions to the tune of 3-5% of the indemnity portfolio which is expected to take care of any incremental Covid related claims that may be incurred. For H1 2023, claims ratio stood at 79.2% as against 88.8% for the corresponding half of the previous fiscal. The correction was driven by decline in Covid-19 claims which drove the delta in the last period. Correspondingly, expense ratio increased from 24.2% % to 24.4%.
Overall profitability remains supported by income from investments. For fiscal 2022, the impact of modest underwriting performance was offset by a gross investment income of Rs 1,239 crore, resulting in a net profit of Rs 500 crore. For H1 2023 as well, a stable investment income of Rs 692 crore and a reduced underwriting deficit of Rs 227 crore, resulted in a net profit of Rs 321 crore for the period.
The adequacy of reserving done by the company against potential Covid-19 claims which are incurred but not reported or are partially reported, will remain a monitorable.